Subscribe

Shorts

Which Therapy Predicts a Better Response to TIL in Melanoma?

Which Therapy Predicts a Better Response to TIL in Melanoma?

a year ago

by

Michael T. Lotze, MD

Marcela Maus, MD, PhD on Autologous vs. Allogenic Therapies

Marcela Maus, MD, PhD on Autologous vs. Allogenic Therapies

a year ago

by

Marcela V. Maus, MD, PhD(+1 more)

Unexpected Results in CAR T Cell Therapy Study in Glioblastoma

Unexpected Results in CAR T Cell Therapy Study in Glioblastoma

a year ago

by

Marcela V. Maus, MD, PhD

The History and Evolution of CAR T Cell Therapy

The History and Evolution of CAR T Cell Therapy

a year ago

by

Marcela V. Maus, MD, PhD